The Board of Directors of Sanofi India on Wednesday approved the recommendation for payment of a final dividend of ₹181 for a equity share of ₹10 each for the year ended December 2021 and a special dividend of ₹309 a share. The company plans to issue dividends after considering the slump sale and transfer of its nutraceuticals business during the year and reviewing the cash requirements for the company's operations. Shares of Sanofi India closed 2 per cent higher at ₹7277.45 on the BSE.
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.